Erlotinib: Lacking of Cholinergic Effects on Tracheal Smooth Muscle
This study demonstrated that erlotinib had no cholinergic effects in vitro, suggesting it may be safe for asthmatic patients with non-small-cell lung cancer after further investigation.
Source: Journal of Experimental and Clinical Medicine - Category: Journals (General) Source Type: research
More News: Allergy & Immunology | Asthma | Cancer | Cancer & Oncology | General Medicine | Lung Cancer | Non-Small Cell Lung Cancer | Oral Cancer | Study | Tarceva | Tracheal Cancer